What Factors Can Predict Response to HER2-Directed Neoadjuvant Therapy?

Several clinicopathologic features of HER2-positive breast cancer patients were found to be associated with response to neoadjuvant therapy in a new study.

Source: CancerNetwork - October 16, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news